News

Welcome to the NNECOS Blog!

Please click on the orange RSS box below to subscribe to this blog.


  • 09 Jun 2016 12:15 AM | Lori Aubrey (Administrator)

    NNECOS Board member Amy Litterini, PT, DPT served as the delegate for this historic approval! 

    https://www.facebook.com/NNECOS/photos/a.246262778839742.63194.244030432396310/854281611371186/?type=3&theater

  • 19 May 2016 3:56 PM | Lori Aubrey (Administrator)
  • 28 Apr 2016 2:27 PM | Lori Aubrey (Administrator)

    http://nnecos.org/classifieds

  • 21 Mar 2016 5:24 PM | Lori Aubrey (Administrator)

    FDA expands use of Xalkori

    Packaging/Label Updates

  • 10 Mar 2016 11:05 AM | Lori Aubrey (Administrator)

    http://www.asco.org/advocacy/learn-how-your-practice-can-test-ascos-payment-reform-model-and-move-forward-macra

  • 09 Mar 2016 12:14 PM | Lori Aubrey (Administrator)

    http://www.asco.org/press-center/cms-proposal-modifying-asp-misses-mark-when-rational-payment-reform-needed

  • 07 Mar 2016 7:52 PM | Lori Aubrey (Administrator)

    NNECOS signs on to the community letter to CMS regarding a proposed rule that will outline a demonstration project around altering the average sales price of drugs in certain regions.

    http://nnecos.org:80/resources/Oncology%20ASP%20Letter%203-7-16.pdf

  • 02 Mar 2016 1:50 PM | Lori Aubrey (Administrator)
    U. S. Food and Drug Administration approved everolimus (Afinitor , Novartis)
    http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm488028.htm

    FDA  approved obinutuzumab (Gazyva Injection, Genentech, Inc.)

    FDA Approves palbociclib (IBRANCE Capsules, Pfizer, Inc.)

    http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm487080.htm


    FDA Approvals


  • 13 Feb 2016 10:07 AM | Lori Aubrey (Administrator)

    FDA Approves Single-Dose fosaprepitant dimeglumine

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software